125.000 – Drugs: Substitution

E-125.001: Drugs: Substitution, Consult Physician First

IMS believes pharmaceutical and therapeutic substitution by pharmacists is appropriate only after consultation with and approval by the prescribing physician. ...

E-125.001: Drugs: Substitution, Consult Physician First

IMS believes pharmaceutical and therapeutic substitution by pharmacists is appropriate only after consultation with and approval by the prescribing physician. ...

E-125.002: Drugs: Substitution, Hospital Formularies

IMS supports the concept that pharmacists employed by and dispensing in a hospital may exercise professional judgment by selecting drugs from a formulary in ...

E-125.002: Drugs: Substitution, Hospital Formularies

IMS supports the concept that pharmacists employed by and dispensing in a hospital may exercise professional judgment by selecting drugs from a formulary in ...

E-125.003: Drugs: Substitution, Formularies Agreed To

IMS opposes legislation authorizing substitution by pharmacists of therapeutic alternates. In taking this action, however, it noted that it does not include formularies ...

E-125.003: Drugs: Substitution, Formularies Agreed To

IMS opposes legislation authorizing substitution by pharmacists of therapeutic alternates. In taking this action, however, it noted that it does not include formularies ...

H-125.004: Drugs: Substitution, Formularies

IMS supports physicians being particularly vigilant in ensuring that formulary decisions of health plans adequately reflect the needs of individual patients; that ...

H-125.004: Drugs: Substitution, Formularies

IMS supports physicians being particularly vigilant in ensuring that formulary decisions of health plans adequately reflect the needs of individual patients; that ...

H-125.005: Drugs: Substitution, Health Plan Disclosure of Formularies/Effect on Drug Benefit

IMS believes that patients must be fully educated to understand methods used by their health plans to limit prescription drug costs. As such, during patient ...

H-125.005: Drugs: Substitution, Health Plan Disclosure of Formularies/Effect on Drug Benefit

IMS believes that patients must be fully educated to understand methods used by their health plans to limit prescription drug costs. As such, during patient ...

H-125.006: Drugs: Substitution, Third Party Payer Drug Policies

IMS encourages physicians who participate in health plans to maintain awareness of plan decisions regarding drug selection by pharmacy and therapeutics...

H-125.006: Drugs: Substitution, Third Party Payer Drug Policies

IMS encourages physicians who participate in health plans to maintain awareness of plan decisions regarding drug selection by pharmacy and therapeutics...

PF-125.007: Drugs, Substitution, Advance Notice of Changes to Drug Formularies

IMS adopts AMA policy H-125.979: Private Health Insurance Formulary Transparency. ...